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ABSTRACT: The calmodulin antagonist W7 binds to troponin C in the presence of Ca
2+ and inhibits striated
muscle contraction. This study integrates multiple data into the structure of the regulatory domain of human
cardiac troponin C (cNTnC) bound to Ca
2+ and W7. The protein-W7 interface is defined through a three-
dimensional{
1H,
13C}-edited-{
1H,
12C}-detectedNOESYNMRexperiment,andotheraspectsofthestructure
are modeled as perturbations to previously known coordinates and restraints. The structure determination
protocol optimizes the protein-W7 contacts prior to the introduction of protein-W7 steric interactions or
conformationalchangesintheprotein.Thestructuredeterminationprotocolgivesfamiliesofconformersthat
all have an optimal docking as assessed by satisfaction of the target function. The structure supports the
previously proposed troponin I blocking mechanism for the activity of W7 in striated muscle and suggests a
role for the flexible tail of W7 in stabilization of the bound state. This clarifies the structure-activity
relationships of W7 and implicates an electrostatically mediated component of activity in common analogues
of W7, including the antipsychotic trifluoroperazine and the cardiotonic levosimendan.
High-quality protein structural models offer new insights into
biochemical mechanisms and new points of departure for experi-
mentation. Each protein crystal represents not only a possible
protein X-ray structure but also a host of potential protein-
ligand costructures. If ligand binding does not cause a large
perturbation tothe conformationof the protein, the costructures
can be obtained by soaking the previously determined crystal in
mother liquor containing the ligand. The high solvent content of
proteincrystalsallowsthe ligandtopenetratethelatticeandbind
to the protein. If the resulting crystals are isomorphous to the
previously determined one, the structure and location of the
ligand can be determined from a difference Fourier map which is
easy compared with the determination of a new X-ray structure
from scratch.
NMR
1 data can be easily acquired for a panel of homologous
protein3ligand complexes. However, there is no widely used
NMR approach similar to the crystallographic methodology of
crystal soaking and model building through a difference Fourier
map, bootstrapping the determination of a protein-ligand
structure through the assumption of a small perturbation to a
known one. This is unusual since NMR provides so many
structurally correlated observations; even a simple titration
experiment can directly show the magnitude and nature of a
binding-induced perturbation. One popular docking protocol
using minimal information is HADDOCK (High Ambiguity
Driven protein-protein DOCKing) (1). This algorithm is used
for the structure determination of complexes of biomolecules
(proteins and nucleic acids) with known structures. HADDOCK
can incorporate highly ambiguous information such as titration-
monitored chemical shift perturbations and can be used to
contrast scenarios where unambiguous knowledge (like intermo-
lecular NOEs) is used for structure determination (1).
We sought a HADDOCK-like protocol appropriate for the
docking of druglike molecules to structures previously deter-
mined by our own group, more closely akin to the crystal-
lographic approach. Our research has described the
conformation of the regulatory N-terminal domain of human
cardiac troponin C in three biological states [off, on, and bound
to cNTnC3Ca
2+’s biological target, a region of troponin I called
the switch peptide (Sp)] and one chemotherapeutic state (bound
to Sp and bepridil) (2-4). Each of those studies represents a
uniquestructuredetermination,eventhoughthestructuresareall
highly similar to each other. Similarly, Ikura and co-workers
determined the calmodulin NMR structure (5)a n dt h e n
determined the structure again in the presence of the model
ligand W7 (6).
Previous work has shown that W7, a known inhibitor of
striated muscle contraction, targets TnC in the muscle fiber (7).
The proposed mechanism has W7 binding to the calcium-bound
N-terminaldomainofhumancardiactroponinC(cNTnC3Ca
2+)
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and interfering with the association of cNTnC3Ca
2+ with Sp.
This makes the cNTnC3Ca
2+-W7 equilibrium an attractive
modelsystemforthedevelopmentofdrugsthatmodulatecardiac
contraction (8). NMR studies have shown that W7 binds to
cNTnC3Ca
2+ and effects the biologically pivotal closed-to-open
conformational transition (9, 10). W7 binding can occur in
the presence of Sp, albeit anticooperatively (10). All of these
observations are in accord with previous results on the cNTnC3
Ca
2+-bepridilsystem(4).AstheCa
2+dependenceoftheTnC-
W7 interaction is independently known (11), the conformational
transition resulting from binding is independently character-
ized (9, 10), and the coordinates of analogous protein-ligand
complexes are known (4), we sought to bootstrap a cNTnC3
Ca
2+
3W7structuredeterminationusingthepreviousknowledge,
analogous to the crystallographic approach using crystal soaks
and difference Fourier maps.
Our early attempts to describe the structure of W7 bound to
cNTnC3Ca
2+ focused on the characterization of the solution
equilibrium. Although 41 backbone amide {
1H,
15N}-HSQC
signals monitored during a W7 titration could be fit to a
single-site binding model, numerous side chain methyl
{
1H,
13C}-HSQCsignalsreflectedasecondarybindingprocess(9).
Attemptstoderivea structureofthecNTnC3Ca
2+
3W7 complex
wereconfounded by multiplebinding sites and/orthe presenceof
multiple docked poses (12). This latter complication was also
identified in the highly analogous calmodulin-J8 system (13). In
this study, we circumvent these difficulties by studying a 1:1
complexandusingafiltered,editedNOESYexperimenttoassign
specific intermolecular contacts.
As W7 binding induced conformational changes in cNTnC3
Ca
2+ thatweresimilar(asmonitoredbyNMR)tothoseinduced
by the binding of Sp (9, 10), we investigate the assumption that
the distance restraints used to define the protein conformation
can be reused from the study defining the structure of the
cNTnC3Ca
2+
3Sp complex. Wepropose that the obligatory data
toward defining the protein-ligand complex are the actual
contacts between cNTnC3Ca
2+ and W7. As calcium binding is
a known prerequisite for binding, as the protein conformation is
to be approximated from analogous structures, and as the
protein-W7 contacts can be precisely and accurately known
(from experimental data presented here), a structure determina-
tion blending these different data must correctly weight their
relative information contents. So in this paper we incorporate
multiple independently procured lines of evidence toward the
structure of cNTnC3Ca
2+
3W7. The structure supports a Sp
blocking mechanism for the activity of W7 in striated muscle and
helps elucidate the role of the flexible tail of W7 in binding.
MATERIALS AND METHODS
Reagents. The cloning, mutagenesis, and expression of the
N-terminaldomainofhumancardiacTnC(C35S,C84S,residues
1-89) have been reported previously (14). W7 [N-(6-aminohex-
enyl)-5-chloronaphthalenesulfonamide] was purchased from
Sigma-Aldrich as a hydrochloride salt. Calcium chloride
(Sigma-Aldrich) and DSS-d6 (Chenomx Inc.) were purchased
as analytical-grade stock solutions.Other reagents wereprepara-
tion-grade. Isotopic labels were purchased from Cambridge
Isotope Laboratories.
AssignmentofW7. TheNMR spectrum ofW7inDMSO-d6
at 30 C was assigned using natural abundance
1Ha n d
13C
spectra acquired on a 10 mM sample on a four-channel Varian
600 MHz NMR Inova spectrometer with a Z-pulsed field
gradient probe, or a 215 mM sample on a Varian Inova 800
MHzspectrometerequippedwithaZ-gradientHCN5mm“cold
probe”. The acquisition parameters at 600 MHz were as follows:
{
1H,
13C}-HMBC, 8000 Hz spectral width in the directly detected
(
1H) dimension (sw), 2200 Hz spectral width in the indirect (
13C)
dimension (sw1), 61 ms acquisition time (at), 144 indirectly
detected points (ni), and the carbon-proton scalar coupling set
to165Hz;{
1H,
13C}-HSQC,sw=8000Hz,sw1=2200Hz,at=
61 ms, ni = 144, and jCH = 143 Hz; {
1H,
1H}-DQF-COSY,
sw= 8000 Hz, sw1 = 8000Hz, at = 256 ms,andni= 512; one-
dimensional
1H, sw = 8000 Hz, and at = 4.0s; one-dimensional
13C, sw = 20000 Hz, and at = 0.5 s, with broadband Waltz16
decoupling. The sample was not spun. Acquisition parameters at
800 MHz for one-dimensional
13C were sw = 5000 Hz (centered
on the aromatic region) and at = 4.0 s, with Waltz16
1H
decoupling and sample spinning. All NMR experiments were
conducted in Biopack using VnmrJ 2.1B (Varian Inc.).
TitrationStudies. Concentrations weredetermined gravime-
trically to a precision of (0.05 mg. Initially, the buffer was
comprised of 100 mM KCl, 10 mM imidazole, DSS-d6 (83 μM),
CaCl2 (4.9 mM), and W7 (1.5 mM) in D2O. Immediately before
the titrationexperiments, 0.5μL of1 M imidazole equilibrated in
H2O was added to the 500 μL NMR sample to provide an
internal pH reference (15). Protein was titrated into the W7
solution either asa drypowder(titration1)or asa bufferedstock
solution (titration 2). For titration 1, the initial pH (technically
a pD as the solvent is D2O) was adjusted to 6.8.
Weighed amounts of lyophilized cNTnC were transferred to
the W7 solution. Significant pH corrections were required over
thetitrationasthelyophilizedproteinisacidic.Resultantchanges
in pH were detected by
1H NMR spectra (15) and were corrected
through additions of 0.1-1 M NaOD or DCl. At each pH-
corrected increment,
1HNMRspectrawereacquired,includinga
T1 relaxation series (see below). For titration 2, the initial pH of
the NMR sample was adjusted to 6.8. A stock 2.0 mM cNTnC
solution was prepared under matched conditions. The pH was
adjusted to a range of 6.5-7.0, measured with pH paper; 10 μL
increments of protein were added to the sample at each titration
point,andsmallaliquotsofacidorbasewereaddedtomaintaina
constant pH.
Titrations were monitored using one-dimensional
1HN M R
(600MHz)spectraacquiredat30C.Thesampleswerenotspun.
SpectrawereprocessedwithNMRPipe/NMRDraw(16).Proces-
sing featured mild apodization and zero filling prior to Fourier
transformation in both dimensions, and forward-back linear
prediction in the indirect dimension. The spectra were referenced
internally to the DSS signal. Peak picking and analysis was
performed with the NANUC distribution of NMRView (17)a s
maintained by P. Mercier (Chenomx Inc.). Increments of titra-
tion 1 (above) were also monitored with
1H T1 relaxation series.
The “water” experiment of BioPack was used, with an initial
equilibration delay (d1) of 2.5 s, and a 4.0 s acquisition. A 180
pulse (15.6 ms) was followed by a variable relaxation delay (d2)
and a readout pulse. The relaxation delay was incremented as
follows: 0.01, 0.0225, 0.0508, 0.1145, 0.2580, 0.5814, 1.3104,
2.9532, 6.6557, and 15 s (an exponentially distributed sampling,
generated with the Parameter Arrays submenu of VnmrJ 2.1B).
Spectra were processed with 0.5 Hz exponential line broadening
in VnmrJ; relaxation analysis was performed within that pro-
gram. Peak intensities were quantified with drift correction using
the macro “fpdc”. The data were fit and visualized with theArticle Biochemistry, Vol. 48, No. 24, 2009 5543
commands “t1 expl” (Figure Supp-1 of the Supporting Informa-
tion). The multiple J-coupled lines corresponding to an indivi-
dual signal wereaveraged along withtheirerrors.Thisprocedure
was performed for free W7 in buffer (titration increment 0) and
for W7 in the presence of 18% (molar ratio) cNTnC3Ca
2+
(titration increment 2; see Table 1).
Intermolecular NOEs. A 1:1 complex was prepared under
the same solution conditions that were used for the binding
experiments (100 mM KCl, 10 mM imidazole, 83 μMD S S - d6,
and 4.9 mM CaCl2); 2.7 mg of lyophilized {
13C,
15N}-enriched
cNTnC and 0.2 mg of W7 were dissolved in a final volume of
550 μLt og e n e r a t e∼0.8 mM 1:1 complex.
Intermolecular NOEs were obtained using a three-dimen-
sional, {
1H,
13C}-edited,
12C-filtered, transferred NOESY experi-
ment(18)includedinBiopack(VarianInc.).Achiefadvantageof
this pulse sequence is that the directly detected dimension does
not require
13C decoupling, allowing long acquisition times and
therefore higher digital resolution. The three-dimensional (3D)
spectrumwasacquiredat800MHzwithsweepwidthsof8000Hz
in the directly detected (W7) dimension, 8000 Hz in the indirect
(protein) dimension, and 4022 Hz in the indirect (protein
13C)
dimension. There were 2048, 160, and 64 complex points
acquired in the direct
1H, indirect
1H, and indirect
13C dimen-
sions,respectively. The datawere processed withNMRPipe(16).
Strong apodization was required because the long acquisition
time resulted in too much incorporation of noise into the
indirectly detected dimensions. The direct dimension was apo-
dized with an unshifted squared cosine function, and a 5 Hz line
broadening was imposed with an exponential window. Forward-
back linear prediction was used in the indirect dimensions.
Spectral assignment was facilitated with NMRView and
NMRViewJ. Titration data and assignments from previous
studies (9, 10) were also used to interpret the intermolecular
NOE data. Strip plots of the assigned contacts are shown in
Figure5.Theassignedmethylgroupsinvolvedinthe31protein-
ligand contacts are highlighted in Figure Supp-2 of the Support-
ingInformation.EachassignedNOEwasinterpretedasacontact
without further interpretation of the significance of peak inten-
sities. One reason for this strategy is that it avoids the problems
inherent in calibrating NOE intensities in the presence of
chemical exchange.
NOETargetFunctions.TherearethreeclassesofNOEdata
used in this study corresponding to various degrees of inductive
support. For example, W7 binds only to calcium-saturated
cNTnC (11), so the distance restraints defining the protein-
Ca
2+ interactions [pseudo-NOEs derived from crystal struc-
tures (2)] were given a scaling of 1000. The calcium ion remains
docked over the entire simulation, and so the magnitude of its
scaling does little to alter the convergence of the calculation,
excepttoensurethattheserestraintsarenotviolated.Incontrast,
the intraprotein NOE data are taken from the structure determi-
nation of Protein Data Bank (PDB) entry 1MXL (cNTnC3
Ca
2+
3Sp, reflecting the open conformation) where the calibra-
tion of the restraints was highly precise. As described below, the
optimal docking solution does require some conformational
changes in the protein, so the intraprotein restraints needed to
be deweighted in favor of the more pertinent data. As such, the
intraprotein restraints were defined with a default scaling of 1.
The most informative restraints, those derived from the cNTnC3
Ca
2+-W7 NOEs in this study, were applied with a scaling of 10
so that they would dominate the intraprotein restraints in the
calculation. They were all calibrated between the same distance
bounds (1.8 and 5 A ˚ ) and were applied with “hard” (quadratic)
scaling at their extrema. NMR assignments and distance re-
straintsareavailableattheBiologicalMagneticResonanceBank
(accession number 16190).
W7 Coordinates and Topology. The computational repre-
sentationofW7wasdefinedwiththeHIC-Upserver(http://xray.
bmc.uu.se/hicup/) (19) and XPLO2D (ftp://xray.bmc.uu.se/pub/
gerard/xutil/) (20) and was manually checked. Xplor-NIH does
not incorporate the W7 DIHEdral energy terms from the
parameter files, leading to a lack of planarity in the naphthalene
moiety of W7. We demonstrated this by obtaining identical
results with and without the DIHEdral terms. Consultation with
the primary author and maintainer of Xplor-NIH, C. Schwieters
(National Institutes of Health, Center for Information Technol-
ogy), led to the decision to restrain the aromatic ring atom
planarity directly with a patch to the IVM module. There is a
crystal structure determination of W7 that is consistent with this
target geometry (21). The coordinate, topology, and parameter
files are included as Supporting Information.
Protein Coordinates and Topology. Initial coordinates
werederivedfromconformer1 ofthe cNTnC3Ca
2+
3Sp3bepridil
NMR ensemble (PDB entry 1LXF). Control calculations were
also performed using the coordinates from PDB entries 1MXL
and 1SPY (cNTnC3Ca
2+
, reflecting the closed conformation).
The proteintopologywasgenerated at runtime fromits sequence
using the Protocol module of Xplor-NIH.
Restrained Docking Protocol. As i m u l a t e da n n e a l i n g
script, appropriate for NOE-driven docking, was derived from
the Xplor-NIH example script, gb1-anneal.py. The script is
provided as Supporting Information. All molecular dynamics
and energy minimizations were performed with Xplor-NIH’s
IVMmodule(22).Ateachstageintheprotocol,thetotaltimecan
be stipulated and Xplor-NIH varies the step size automatically
according to the simulation temperature, the size of the energy
gradient, and a parameter approximating the error in the
integration of the energies (the ETolerance). In this protocol,
short molecular dynamic trajectories are coupled to Powell
minimizations having dEPred (the expected energy decrease per
step) set to the ETolerance (dEPred = ETolerance).
Dynamics were performed in torsion space except for the
initialandfinalminimization.Threegroupingsofpotentialterms
Table 1: Chemical Shifts of W7 in the Free State in NMR Buffer and T1
Relaxation Times of the W7 Protons Free and in the Presence of 18%
(molar ratio) cNTnC3Ca
2+
3W7 Complex
a
T1 (s)
signal shift (ppm) free W7
18% (molar ratio)
cNTnC3Ca
2+
3W7
H2 8.34 3.45(0.105 1.53(0.063
H3 7.80 2.37(0.055 1.56(0.066
b
H4 8.58 3.02(0.061 1.60(0.092
H6 7.87 3.77(0.071 1.56(0.066
b
H7 7.72 2.36(0.050 1.59(0.072
H8 8.70 3.48(0.075 1.56(0.094
H11 2.95 0.804( 0.007 0.850(0.029
H12 1.24 0.895(0.032 1.04( 0.095
b
H13/14 0.97 0.921(0.015 0.896( 0.048
H15 1.30 1.21(0.029 1.04(0.095
b
H16 2.75 1.54(0.021 1.04(0.017
aNote that signals H11-H16 correspond to two methylene protons.
bT1 values correspond to more than one signal due to spectral overlap.5544 Biochemistry, Vol. 48, No. 24, 2009 Hoffman and Sykes
were defined over the simulation. The “base potentials” include
all of Xplor-NIH’s nonbonded potentials, the intraprotein dis-
tance restraints, and the calcium ion restraints. The “docking
potentials” included all of the base potentials as well as the
protein-W7 distance restraints. The “refinement potentials”
included the docking potentials, Xplor-NIH’s RAMAchandran
(backbone dihedral angle database) potential (23), and the
HBDB (dynamic hydrogen bonding) potential (24).
InitialcoordinatesofW7andcNTnC3Ca
2+wereseparatedby
more than 80 A ˚ . Initial velocities were assigned, and the system
was equilibrated against the base potentials. During this time, all
of the base potential terms were minimized while sampling a
small region of conformational space. Next, all protein
atoms were immobilized with respect to each other. Any steric
(VDW term) interactions between W7 and cNTnC were elimi-
nated. Random velocities were reinitialized, and the system was
equilibrated under the docking potentials. Minimization
ofthedockingpotentialscausedtheligandtodocktoaphysically
impossible location where it would sterically clash with the
protein.
The next phase of the calculation reintroduces the steric
interactionsbetweenproteinandW7atoms.Thisisdonethrough
successive rounds of increasing the scaling of the protein-ligand
stericinteraction,initializingrandomvelocities,andequilibrating
the system (at 25K), and minimization. Forces generated from
theseinteractionsdonotimpacttheprotein’sbackbonegeometry
asbackboneatomsarefixedatthistime.Instead,thetermsofthe
dockingpotentialsequilibrateovertheconfigurationspaceofthe
side chains. Although this stage of the protocol reintroduced the
intermolecular steric interaction and consistently minimized the
docking potentials, the intermolecular NOE term was never
completely satisfied.
In the last stage of the calculation, the velocities from the
previous dynamics run were inputted, and the system was
equilibrated with all protein atoms reconfiguring against the
refinement potentials. During this time, all terms of the docking
potential were greatly satisfied: the intermolecular NOE target
function usually dropped below 1 kcal/mol (recall, this term is
scaled20-foldtotheintraproteinNOEterm).Furtherrefinement
ofthisstructurefollowedfromconsecutivecyclesofequilibration
for 1 ps and Powell minimization. A final minimization in
Cartesian mode was performed and the structure outputted.
Ramachandran analysis was performed with Procheck (25). The
10 lowest-energy structures calculated without extra refinement
potentials,butwithapositivechargeonW7’saminenitrogen,are
deposited as PDB entry 2KFX.
The Xplor-NIH binary used was downloaded directly from
the National Institutes of Health (version 2.21). As the compu-
tation time for a structure is dynamically varied over the proto-
col according to the requested ETolerance and the instan-
taneousenergygradient,structuresdeterminedwiththisprotocol
take a varying amount of computational time. A representa-
tive calculation of 50 structures took 291 min on a computer
with 2   2.66 GHz dual-core Intel Xeon processors (using a
single core for the calculation), or 5.82 min per structure per
core.
RESULTS AND DISCUSSION
Assignment of W7. DMSO was the preferred solvent for
the assignment of W7, as this allowed for the preparation
of concentrated samples, useful for natural abundance
13C
spectroscopy. The
1Ha n d
13C NMR spectra of W7 in DMSO-
d6(Figures1and2)weredifficulttoassign.Themoleculehastwo
symmetrically arranged aromatic proton spin systems. Only the
central spin of each spin system can be identified by
direct inspection of the {
1H,
1H}-DQF-COSY NMR spectrum
(Figure 1, left). Craven and others have previously assigned the
W7analogueJ8throughtheuseofanalogouscompoundslacking
the problematically high symmetry (13). Alternate solvents were
testedtoseeifthechemicalexchangeofthesulfonamidehydrogen
could distinguish it from the amine hydrogens, which appears to
bethestrategyusedbyOsawaandothers(6).W7wasinsolublein
methylene chloride, acetone, and chloroform.
Unambiguous assignments were attained through natural
abundance
13C spectroscopyat high field (Figure 1). The directly
detected
13C spectrum was observed to have a
35Cl/
37Cl isotope
shift for ring C5, giving rise to two
13C signals with the expected
peak separation (1.0 Hz) and relative intensities (26). The key
HMBC correlation supporting the unambiguous assignment
reflects the magnetization transfer shown by the cyan arrows in
Figure 1 at the top left. The expected HMBC correlations are
between ring hydrogens and any carbon atoms in a meta
relationship (27) (but some weaker ortho couplings are also
observed).
The aliphatic tail of W7 (Figure 2) also has a symmetrical
1H
spin system, with six methylene groups connecting two nitrogen
atoms. The DQF-COSY spectrum allows for unambiguous
attribution of the spin system to two ambiguous assignments
differinginwhichterminalmethyleneismostring-proximal.This
ambiguitycanbebrokenwithanadditionalobservationfromthe
titration of cNTnC3Ca
2+ into W7, where the downfield reso-
nance (∼2.8 ppm) undergoes line broadening concomitant with
similar broadening in the aromatic ring atoms (see Figure 3).
Sinceposition11ismoreproximaltothearomaticring,weassign
it to the signal at 2.8 ppm.
Binding of cNTnC3Ca
2+ to W7. The titration of cNTnC
into a W7 sample made up in aqueous buffer is shown in Figure
Supp-3 of the Supporting Information (described in Materials
and Methods as titration 1). This titration is the reverse of
the usual titration of the ligand into the protein sample
and, therefore, can more directly disclose the binding at high
protein:ligand ratios. This experiment was replicated with
more strongly controlled pH (Figure 3). These spectra are
in the NMR fast exchange limit for the chemical exchange
between the free and bound forms, so the W7 resonances (shown
for the free ligand in the bottom trace; the assignments of
W7 in H2O can be directly transferred from DMSO since
the spectra are very similar) can be tracked through the titration
to their final positions as the protein:ligand ratio approaches
1:1. Chemical shifts of W7 in the bound state can be compared
with those assigned for W7 when complexed with calmodulin.
As W7 is titrated into the cNTnC3Ca
2+ system, H4 and
H8 exchange their order on the frequency coordinate; this
is not observed as W7 is titrated into the Ca
2+-saturated CaM
system (6).
The most-downfield W7 signal changes the most upon
cNTnC3Ca
2+ binding and was selected for analysis. The peak
frequencieswereextractedfromthe1DspectrainVnmrJ,andthe
titration curveisplottedinFigure 4. Thesedatacannotbefittoa
single-site binding model as in previous work (9). Also, these
data cannot be fit to a two-site, sequential model. As such,
the appropriate form of a binding model describing this equili-
brium would allow stoichiometries higher than 1:1 binding. TheArticle Biochemistry, Vol. 48, No. 24, 2009 5545
following equilibrium was proposed:
P þ L T P3L T P3L3Ln ð1Þ
where P is the protein (cNTnC3Ca
2+) and L is the ligand (W7).
The model has twoequilibriumconstants, Kd1 and Kd2,e q ua lt o[ P ]
[L]/[PL]and[P3L][L]
n/[P3L3Ln],respectively.Thebindingconstant
for the second step, as well as the stoichiometry of the second
binding event (n), allows for modeling of secondary nonspecific
binding. One mole of P3L3Ln reflects the binding of n + 1 ligand
signals. Although the model, as written, implies a simultaneous
binding of n molecules of ligand, we chose it to absorb the
combined uncertainties of choosing a single Kd2 to summarize
the process and modeling the spectral perturbation of all ligands as
equal in magnitude. So Kd2 and n are covariant parameters.
This model cannot be solved analytically, but numerical
simulation (see Figure 4) allows for confirmation that the form
of the model is appropriate. The following parameter values
were used: Kd1 =1 0 0μM, Kd2 = 0.43 pM, and n =4 .T h e
secondary binding then has a microscopic binding constant of
0.43 pM
1/4 ∼0.8mM. Equation 1,withtheparametersdescribed
above, predicts that at the 1:1 point, the P3L complex populates
83.4% of the protein species, with only ∼0.5% of the protein
species in the nonspecific P3L3Ln complex (the remainder being
free protein). Therefore, appropriate conditions for structure
determination are obtained close to a 1:1 protein:ligand ratio.
Ofcourse,theproposedequilibriumdiffersinmechanismfrom
the single-site fits reported by ourselves (9) and Hidaka and
others (11). As NMR has limited sensitivity, strong binding
events and nonunitary stoichiometries are not always identified.
However, this is offset in part by its tremendous site-specific
resolution. For example, the amide-detected binding in reference
9 could be fit to a single-site binding model, but the Met Cε
signals reported in that study disclose more complicated binding
phenomena. Similarly, Hidaka and others report a single Kd for
the sTnC34Ca
2+-W7 equilibrium, although their Scatchard
plot demonstrates pronounced nonlinearity.
Conformational Dynamics of W7. The T1 relaxation times
of protons are dominated by the dipolar relaxation mechan-
ism (28). Thearomatic protons of unboundW7showtwo classes
ofrelaxationtimes(Table1).Thecontributionofavicinalproton
to dipolar relaxation accounts for the substantially shorter T1
values for protons at positions 3 and 7 compared with the other
ring protons. The expression
1=T1  Nðγ4p
2=rHH
6Þτ
FIGURE 1: AssignmentofthearomaticsysteminW7.Theprotonsformtwospinsystems,withonlythecentralspins(protons3and7)formingan
ambiguouspair.Thetwospinsystemsareshownwithgreenororangecorrelationsinthe{
1H,
1H}-DQF-COSYspectrum[two-dimensional(2D)
spectrum atleft]. We resolve this ambiguity with a high-resolution
13C one-dimensional spectrum (top right), which shows a single 1 Hz splitting
because of the
35Cl/
37C
13C isotope shift; this observation unambiguously identifies C5. The {
1H,
13C}-HMBC spectrum (2D spectrum at right,
with colored peaks) shows the expected two-bond correlation between H7 and C5. This also disambiguates H3 by exclusion. These assignments
arefurthercorroboratedbytheabsenceof{
1H,
13C}-HSQCpeaks(2Dspectrumatright,blackpeakswithlabelscorrespondingtoproton-carbon
pairs) at the
13C frequencies for C5 and C9. The other HMBC signals correlating to C5 and C9 arise from H4. With the proton and carbon
assignments for positions 3 and 4, position 2 is known by exclusion. Position 8 is identified from its HMBC correlations to C1 and C10, leaving
position 6 assignable by exclusion.5546 Biochemistry, Vol. 48, No. 24, 2009 Hoffman and Sykes
describes
1H T1 relaxation times for a dipolar mechanism in the
extreme narrowing limit (τω , 1), where τ is the rotational
correlation time for a W7 proton, ω is the spectrometer
frequency, and N is the number of proton neighbors. In this
limit, T1 is inversely correlated with the correlation time. The
value of rHH is much shorter for the tail protons than the
FIGURE 3: BindingofcNTnC3Ca
2+toW7,monitoredwith1D
1Hspectra.AbufferedstocksolutionofcNTnC3Ca
2+ wasused,affordingmore
control over the pH changes over the titration. The protein:W7 ratio is shown to the right of each spectrum. cNTnC3Ca
2+ binding induces
chemicalshiftchanges.Thebindingcurverisesmoresteeplythanwouldbeobservedfor1:1binding.Theequilibriumcanbemodeledintermsofa
microscopicaffinitysimilarinmagnitude,however(Figure4).AssignmentsforW7intheunboundstate(Figures1and2)weretransferredtothose
of the bound state through these spectra.
FIGURE 2: {
1H,
1H}-DQF-COSY NMR subspectrum of the aliphatic tail of W7. Although the spin system can be unambiguously attributed,
assignmentoftheterminalpositions(11,16)requiresadditionaldata.Consideringthatthelinewidthofthemoredownfieldsignallinebroadensin
responsetocNTnC3Ca
2+bindingconcurrentwiththebroadeninginthearomaticring(Figure3),wetakethatsignaltobethemorering-proximal
signal (position 11).Article Biochemistry, Vol. 48, No. 24, 2009 5547
aromatic protons, so the T1 values are expected to be shorter for
the tail protons. The mobility of the qth tail atoms can be
approximated, relative to those in position 11.
τq=τ11 ≈ T1,11=T1,q
Table 2 lists the incremental mobilities for the W7 tail atoms
calculated from the measured relaxation times using the above
relationship. Protein binding serves to globally shorten the T1
values and make them more uniform. This may reflect changes in
mobility(indicatingthatthetailofW7islessmobilewhenbound),
contributions to relaxation from additional proton neighbors, and
spin diffusion when it is bound to the protein. Detailed inter-
pretation of these data is limited from ambiguities in the binding
equilibrium; as modeled above, the sample at this point (18%
protein:W7 molar ratio) contains almost equal quantities of the
1:1 complex and the higher-order, nonspecific complexes.
NMR Structures. The structure calculation consisted of the
simulation of 50 conformers with different random seeds for all
velocityinitializations. Twovariables werepermuted, giving four
NMR ensembles.One variable was the introduction of a positive
charge into the amine nitrogen of W7. Ensembles with this
manipulation have names appendedwitha Q.The other variable
was the incorporation of Xplor-NIH’s refinement potentials, as
describedinMaterialsandMethods.Ensembles withthismanip-
ulation are named “refined” as opposed to “plain”. Table 3
summarizes some of the properties of the four ensembles. All
ensembles extensively minimize the target (docking) potential. In
terms of convergence of the solution and maximal satisfaction of
the docking potential, the “plainQ” calculation was most attrac-
tive and was selected for further analysis.
The 50 structures vary in the residual energy in the docking
term, from 0.017 to 0.175 kcal/mol; 46 of the 50 calculated
structures had no violations in the docking term (the other four
structureshadasingleviolation.)AsshowninFigure6,theentire
ensemble positions W7 similarly, with the only remaining point
of convergence being the details of the pose. Considering the 10
best solutions (lowest energies overall), a single pose is favored
with a defined conformation for W7’s tail (Figure 7). None of
these structures have violations in the docking term, although
they do have other inadequacies.
Many of these limitations (including stereochemical quality)
reflect sources of imprecision external to the docking term: a
control calculation sharing the plainQ simulation parameters
but lacking the docking potential gave similar energies and
Ramachandran statistics. WHAT-CHECK (29)r u n so nt h e
initial coordinates (PDB entry 1LXF), the coordinates deter-
mined with our intraprotein restraints (PDB entry 1MXL), and
structures calculated in this study (PDB entry 2KFX) all gave
poor scores in a number of metrics, especially intramolecular
contacts or “bumps”. These close contacts for 2KFX were not
corroborated by the (ADIT) upload servers for the PDB or
BMRB. The inclusion of solvent may improve the agreement
with target metrics (30); however, this study blends prior and
posteriorinformationina way that presupposessomeamount of
disagreement between an accurate structure and the intraprotein
restraints. Further refinement of the solution in the presence of
violated restraints is likely an exercise in over-refinement.
In contrast to the intermolecular distance restraints, the
intraprotein restraints used to define the open conformation of
cNTnC3Ca
2+ (3), though well-validated by a subsequently
determined crystal structure (31), are only approximately valid
when applied towarda cNTnC3Ca
2+
3W7 complex. They canbe
considered control restraints. As such, should ligand binding
deform the protein conformation beyond the previously deter-
mined conformation, the control restraints will report the
discrepancy by increasing the system’s energy. Should ligand
binding prove to be completely compatible with the intraprotein
NOEs, this would further illustrate how the information content
of the intraprotein NOEs may not unambiguously define a
conformation, although a single-conformer interpretation of
the NOE tends to give highly converged structures (32).
All structures had some violations in the intraprotein NOE
term; the 10 best solutions have residual NOE energies in the
range of 3.9-5.3 kcal/mol, amounting to four to six violations.
There were 17 different violated intraprotein restraints, with
seven restraints being violated in the majority of structures. Of
these, four were long-range restraints. One restraint, colocalizing
atoms from Met80 and Phe27 to 3.85 A ˚ , is violated (calculated
distance of ∼7A ˚ ) because Met80 instead stabilizes W7 in the
complex. Two other violated restraints colocalize Phe27 and
Leu41 (target distance of 3.56 A ˚ ) and colocalize V28 and Ser35
(target distance of 3.07 A ˚ ), with calculated distances of ∼6A ˚ .
These restraints are close to the (defunct) site 1, which may vary
from the coordinates of 1MXL, especially since this region
undergoes conformational exchange in solution (33). Also, a
restraint between the HN group of Glu66 and Hγ1 of Glu76 was
usually violated (target distance of 2.98 A ˚ ; calculated distance of
∼5A ˚ ). This violation may reflect a competition (frustration)
between the intraprotein and Ca
2+-coordinating potentials.
As the docking is effected through 31 distance restraints,
these data could be exhaustively cross-validated (Figure 6B).
FIGURE 4: Simulation of cNTnC3Ca
2+-W7 binding equilibria.
The downfield W7 signal (H8) from titration 2 (Figure 3) can be fit to
an n + 1 site, sequential binding model, where n is the number of
secondary(nonspecific)bindingsites.Thecirclesarethedatapoints,and
the closely spaced plus signs reflect the numerical simulation.
The parameter values used are as follows: Kd1 = 100 μM, Kd2 =
0.43 pM, and n =4 .
Table 2: Correlation Times of Tail Atoms Expressed as a Fraction of the
Correlation Time of the Most Ring-Proximal Tail Protons (site 11)
τq/τ11
signal free W7 18% (molar ratio) cNTnC3Ca
2+:W7
H11 1.0 1.0
H12 0.90 1.22
a
H13/14 0.87 1.05
H15 0.66 1.22
a
H16 0.52 1.22
aT1 values correspond to more than one signal due to spectral overlap.5548 Biochemistry, Vol. 48, No. 24, 2009 Hoffman and Sykes
Thirty-onereplica calculationswereperformed (10 structures per
run), each with one restraint inactivated. All cross-validation
trials allowed for good minimization of the intermolecular NOE
term. Some conformers place the orientation of the ring in an
alternate pose; however, no alternate solution was stabilized
consistently over the cross-validation trial. To assess conver-
gence,theresultsoftheserunsarecomparedwithall50structures
of the plainQ ensemble in Figure 6A (not just the low-energy
structures).
Examining both the fully determined and cross-validated
ensemblesshowsthedifferentatomsofW7varyinginconvergence
to differing extents. The two alternative poses pivot the chlor-
onaphthalene group around C1 (the sulfonamide-coupling car-
bon of W7). As such, the level of convergence for some ligand
atoms is quite high, because even low-quality docking solutions
leave the positions unchanged for those atoms. The precision of
the W7 coordinates was quantified by calculating the mean
square deviation from the lowest-energy cross-validation trial
(after alignment of the protein backbone atoms). To report an
estimate of the precision of the ensemble, the root-mean-square
deviation (rmsd) of each atom in W7 was calculated on the basis
of the entire cross-validated trial. Via calculation of these
Table 3: Ensemble Energies and Statistics (best 10 of 50 structures)
Ramachandran plot occupancy (%)
ensemble total energy (kcal/mol) docking energy (kcal/mol) favored additional generous disallowed
plain (ae7b1) 99-106 0.021-0.068 71.8 25.8 2.3 0.1
plainQ (ae7b4) 99-102 0.017-0.057 71.1 26.2 2.7 0.0
refined (ae7b2) -910 to -821 0.068-0.155 85.1 14.3 0.6 0.0
refined (ae7b3) -858 to -825 0.050-0.127 85.3 14.1 0.6 0.0
FIGURE 5: Intermolecular NOEs between W7 and cNTnC3Ca
2+. The NOEs were observed through a {
13C,
1H}-edited, {
12C,
1H}-filtered
NOESY experiment. Signals with positive amplitude (signals, noise, or artifacts) are shown as blue contours, and negative signals (noise or
artifacts)areshownasredcontours.Assignedstripsforagiven
13Crangeareshownasseparatepanelsalongwithmarkersindicatingtheassigned
protein
1Hsignal.Anumberof“bleed-through”signalsthatoriginatefromtheproteinbutsurvivethe
12Cfilteroccurinthearomaticregionofthe
spectrum. To assign these data in the presence of the artifacts, peaks at the ligand frequencies were exclusively considered (labels at top).
FIGURE 6: Allstructurescalculatedinthefullydeterminedandcross-validationtrialsfortheplainQcalculation.Theproteinbackboneisdepicted
withaCRtrace(onevertexperCR)withW7’snon-hydrogenatomsshownassticks.ThearomaticatomsofW7arecoloredblackwiththechlorine
atom depicted as a gray sphere. (A) Complete set of docked structures for ensemble plainQ. The solutions all cluster to the same binding site;
however, additional discrimination (exclusion of higher-energy structures) is required to visualize the most-probable pose. The lowest-energy
structuresfromthisensemblearepresentedinFigure7.(B)Completesetofdockingcross-validationtrialsforensembleplainQ.Depictionsareas
inpanel A.Eliminating singlerestraintsfromthe docking solution does decrease the convergence ofthe ligandpose; however,the localizationof
the binding site is impervious to these perturbations.Article Biochemistry, Vol. 48, No. 24, 2009 5549
precisions from the cross-validated trials, the potential influence
of errors in the intermolecular NOEs is also considered. The
atom-specific rmsds for W7’s non-hydrogen atoms are listed in
Table 4. The atoms surrounding C1 are the most precisely
determined(1-3A ˚ rmsd),andthetailatomsaretheleastdefined
(3-6A ˚ rmsd). It is also useful to estimate the precision of the
protein coordinates. Procheck can assign “equivalent resolu-
tions” based on an ensemble’s conformity to target covalent
parameters. On the basis of the Ramachandran statistics of the
ensemble [the poorest-performing metric assessed by Pro-
check (25)], the equivalent resolution is 2.8 A ˚ .
Structure Determination Protocol. Our procedure for
“crystal soaks by NMR” gradually introduces the protein-
ligand steric interaction after initial satisfaction of the docking
potential. As such, the conformational search is biased toward a
maximally complementary fit following satisfaction of the dock-
ing restraints. An implication of this is that the maximal
conformational search size is a function of the ligand volume,
buttheprotocolusesalargeamountofpriorinformationbesides
ligand volume.
The agreement of the prior data with the new experimental
data can be assessed by noting the residual in the docking
potential following the initial (no-intermolecular-sterics) dock-
ing. At this point of the simulation, the intermolecular potential
has had no opportunity to influence the protein coordinates, so
this term is therefore an independent measure of the agreement
between the prior and posterior data. The ability of this residual
to discriminate between good and poor agreements is now
illustrated through examples with inappropriate choices of prior
information. We know that W7 binding stabilizes the open
conformation of cNTnC3Ca
2+ (9, 10) so the most inappropriate
intraprotein NOEs for the docked complex would reflect the
closed conformation of PDB entry 1SPY (2). The choice of the
initial coordinates and intraprotein NOEs of 1SPY gives an
intraprotein NOE residual of 3.25 ( 0.65 kcal/mol (mean (
standarddeviationoverall50conformers)butdoesnotminimize
the docking residual (314 ( 38 kcal/mol). For the choice of
an inappropriate combination of initial coordinates and intra-
protein NOEs (the initial coordinates from 1SPY with the
intraprotein NOEs of 1MXL), the intraprotein NOE residual is
58 ( 12 kcal/mol and the docking residual is 369 ( 76 kcal/mol.
In contrast, the use of appropriate initial coordinates and
intraprotein NOEs (as in the plainQ calculation) gives a small
residual for the intraprotein NOEs (7.22 ( 3.69 kcal/mol) and
good satisfaction of the docking potential (17.07 ( 6.96 kcal/
mol).The initialdockingresidualsthusprovideastrongcriterion
for the selection of prior data.
The issues surrounding the mutual weighting of known and
assumed information are endemic to structure determination by
NMR,asnoNMRstructureisactuallyoverdetermined.Auseful
approach to this problem is outlined by Nilges and co-work-
ers(34,35),whostressthatstructuredeterminationisanexample
of data inversion and that the weightings of NOE-derived
distance restraints are parameters that should be marginalized.
Inthisstudy,wedonotapplytheinferentialstructuredetermina-
tion protocol, although our approach could be harmonized with
it. An immediately presenting (but nonconfounding) complica-
tion is that inferential structure determination as originally
developed (34) treats the (all of the) NOE data as posterior
knowledge and the target covalent parameters as prior knowl-
edge. Here, the Ca
2+ binding restraints are not derived from
NOEdataatallandingeneralwillnothavesimilarweightingsto
the correctly weighted potential for inverting the NOE data into
FIGURE 7: Tenlowest-energyconformers(best20%)fromtheplainQcalculation.DepictionsareasinFigure6,buttheCa
2+ionsarealsoshown,
asgrayspheres. The non-carbon atoms ofW7are colored gray; hydrogens are not shown. (A) The N-terminal helix (helix N)of cNTnC is atthe
topofthefigurepointingtotheleftanddown.HelixDispointingoutofthepage.(B)Adifferentorientationofthesameensemble.HelicesAand
B are closest to the reader.
Table 4: Root-Mean-Square Deviations for the Non-Hydrogen Atoms of
W7 in the Cross-Validation Trials
atom rmsd (A ˚ ) atom rmsd (A ˚ )
C1 1.077 O2 2.365
C9 1.162 N1 2.944
C2 1.352 O1 3.054
C8 1.367 CL1 3.272
S1 1.666 C11 3.974
C10 1.762 C14 4.429
C7 1.763 C13 4.504
C3 1.909 C12 4.510
C6 2.165 C16 5.061
C4 2.169 C15 5.289
C5 2.269 N2 6.1915550 Biochemistry, Vol. 48, No. 24, 2009 Hoffman and Sykes
distance restraints. Also, marginalizing over all possible weight-
ingsdoesnotreflectourknowledgeofthecausalpriorityofCa
2+
binding to W7 binding, and the high accuracies and precisions
provided by good crystal structures.
A basic limitation to our calculations is that the energy gap
between maximally converged and unconverged ligand poses
is small. Distinction should be made between assessment of
convergence (or precision) and maximal satisfaction of the
target function (which reflects accuracy). As the both the
refined and the refinedQ calculations have higher final values
of the docking potential than either of the plain calculations,
the solution is less accurate. Xplor-NIH’s refinement poten-
tials (the RAMA and HBDB potentials) are not intended to
greatly perturb convergence of the solution. In this study, the
introduction of these two terms perturbed the convergence of
theamine tailconformation(together,and withtheweightings
inherited from the gb1-anneal.py example script). This may
reflect the need for the most pertinent data (the docking
potential) to dominate the simulation energetics. Perhaps
more judicious weighting of the two terms or exclusion of
one of them would improve the backbone stereochemistry of
the model without compromising convergence.
Mechanistic Implications. Ca
2+ binding to skeletal NTnC
(2 molar equiv of Ca
2+) induces a conformational change that
allows it to bind to the switch region of skeletal troponin I (36).
This conformational transition results in the solvent exposure of
a hydrophobic surface and is energetically unfavorable under
ambient conditions. This conformational transition (dubbed
“opening”) has been explained in terms of a cascade originating
withthe reorientationofthesidechains intheCa
2+-bindingsites
and propagating across the tertiary structure (37, 38). A point
mutation of skeletal NTnC (E41A) abolishes the Ca
2+-induced
conformational change (but not Ca
2+ binding), which shows
that opening is effected through a mechanistic cascade, specifi-
cally mediated through the N-terminal Ca
2+-binding site (site
I) (38). In the cardiac system, Ca
2+ binding to site I is defunct,
andthestructureisnotobservedtoopenfollowingthebindingof
1 equiv of Ca
2+. Addition of Sp, however, stabilizes the open
conformation.
When binding is accompanied by conformational changes in
the protein, the change in conformation can precede or follow
from the binding. The former mechanism is called “conforma-
tional selection” and the latter “induced fit”. Both mechanisms
have been advanced throughout the literature in a plethora of
contexts, including the association of cNTnC3Ca
2+ with Sp. In
the induced fit model, Ca
2+ binding to the cardiac system “sets
the stage” for Sp binding, helping to overcome the “energetic
barrier to opening”. The existence of a substantial energy barrier
seemsunlikely,givenresultsindicatingthatcNTnC3Ca
2+under-
goes conformational exchange attributable to opening (33, 39,
40).Furthersupportfortheconformationalselectionmechanism
for the association of cNTnC3Ca
2+ with Sp comes from the fact
that W7 and Sp both stabilize theopenconformation of cNTnC3
Ca
2+ (9, 10). As W7 is a poor structural analogue of Sp (being
aromatic, much smaller, and less functionalized), it seems im-
probable thatitiscapable of mimicking aninduced fit process. A
moreparsimoniousexplanationisthatthetargetpeptideandW7
both bind to and stabilize a preexisting open conformation as in
the conformational selection mechanism.
Structure-Activity Relationships. Previous work has mo-
tivated and supported a “switch-peptide-occlusion” mechanism
for W7’s inhibition of striated muscle contraction (7, 9, 10). This
means that W7 binds to cNTnC3Ca
2+ and impedes the subse-
quentbindingofSp.Theseresultssubstantiatesuchamechanism
becausetheoverallbindingsiteofW7isunambiguouslylocalized
to the previously proposed Sp binding site (see Figure 8). As
shown inFigure9, the W7binding siteissimilar but not identical
FIGURE 8: Comparison of the lowest-energy conformer of the
cNTnC3Ca
2+
3W7 complex with the first conformer of cNTnC3
Ca
2+
3Sp (PDB entry 1MXL). The structures were aligned over the
backbone heavy atoms of residues 2-87 (2.46 A ˚ rmsd). The back-
boneofcNTnC3Ca
2+from1MXLisshownasablackCRtrace.The
switch peptide (cardiac TnI147-163) is shown as sticks, with carbon
atoms coloredlight brown.W7isshownwithblack sticksfor carbon
atomsandwiththesurfacerepresentedasatransparentoutline.This
shows that W7 serically interferes with the stabilizing cNTnC-Sp
interactionsoriginatingfromIle149andMet154.Theterminalamine
group of W7 may compete with Arg148 for electrostatic interactions
with acidic patches on helices C and D.
FIGURE 9: Comparison of the cNTnC3Ca
2+
3W7 structure with the
cNTnC3Ca
2+
3Sp3bepridilstructure(PDBentry1LXF).Thelowest-
energy conformer from the plainQ calculation (black and gray
carbonatoms)isalignedtothefirstconformerof1LXF(lightbrown
carbon atoms, backbone rmsd of 1.50 A ˚ ). The Sp component of
1LXF is not shown. W7’s binding site only partially overlaps
with bepridil’s. The primary amine of W7 colocalizes to one of
bepridil’s tertiary amines. W7 penetrates more deeply into the
hydrophobic pocket of cNTnC3Ca
2+ than bepridil when bound to
cNTnC3Ca
2+
3Sp.Article Biochemistry, Vol. 48, No. 24, 2009 5551
to the location of bepridil when bound to cNTnC3Ca
2+
3Sp.
Both bepridil and W7 bind to cNTnC3Ca
2+
3Sp with
weaker affinity than to cNTnC3Ca
2+ (4, 10); however,
Sp binding does not preclude W7 binding (10), so one could
assumethatSp,whenbound,shiftsthebindingsiteforW7toone
more analogous to bepridil in the cNTnC3Ca
2+
3Sp3bepridil
complex (4).
To date, structure-activity relationships of W7 have been
defined almost exclusively in terms of its hydrophobicity. The
chloronaphthalene moiety is the best-rationalized, as most
explicitly disclosed by the structure of its CaM-bound state (6).
Substitutionofthechlorineatomwithmorepolarizablehalogens
enhances both CaM affinity and biochemical activity (41),
indicating that the bound state is hydrophobically stabilized.
Increasing the tail length of W7 increases its affinity and the
activity in the CaM system but also its hydrophobicity. The
structures of neither CaM34Ca
2+
3W7 nor CaM34Ca
2+
3J8
show ordering in the tail moiety. The T1 analysis (Table 2)
indicates that in the cTnC3Ca
2+
3W7 complex the tail
moiety does order in the complex, consistent with the structure
determination.
As shown in Figure 10, the conformation of W7’s tail in the
bound state places the terminal amine moiety in the proximity of
two acidic patches located on helices C and D. This electrostatic
interaction facilitates maximal satisfaction of the docking poten-
tial (Table 3). By drawing helices C and D closer to each other,
W7mayinterferewiththestabilizationoftheinhibitoryregionof
TnI, which binds to helices D and E of TnC (31). The W7 amine
group may compete with the guanidino moiety of Arg148 of Sp,
which also interacts with the aforementioned acidic patches
(Figure 8). This novel structure-activity relationship for the
amine tail moiety suggests that W7 is bidentate and further
implicates the importance of electrostatic interactions in the
structure-function relationship of troponin C (42).
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